News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Razan Mohty: Outcomes of anti-CD19 CART for lymphoma in octogenarians
Razan Mohty/X
Mar 4, 2025, 04:35

Razan Mohty: Outcomes of anti-CD19 CART for lymphoma in octogenarians

Razan Mohty, Assistant Professor at UAB Medicine, shared a paper she and her colleagues authored on X:

“Happy to share our recent manuscript on outcomes of anti-CD19 CART for lymphoma in octogenarians (80 years of age or older).

– CR rate 71.4%
– 1-year OS 61.2%
– 1-year PFS 47.6%
– 1-year NRM 11.6%

Thanks to all collaborators.”

Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study

Authors: Mohamed A. Kharfan-Dabaja, Razan Mohty et al.

Razan Mohty: Outcomes of anti-CD19 CART for lymphoma in octogenarians

Aaron P. Rapoport Amer Beitinjaneh Amitkumar Mehta Arushi Khurana Bhagirathbhai Dholaria cancer Deepa Jagadeesh Ernesto Ayala Forat Lutfi Frederick L. Locke Javier Munoz Jean Yared Jennifer Logue Jose Sandoval-Sus Joseph McGuirk Joshua Fein Julio C. Chavez Kaitlin Annunzio Lazaros Lekakis Madiha Iqbal Mayur Narkhede Mehdi Hamadani Michael D. Jain Mohamed A. Kharfan-Dabaja Muhamad Alhaj-Moustafa Narendranath Epperla Nausheen Ahmed Neela Easwar Olalekan O. Oluwole OncoDaily Oncology Othman Salim Akhtar Patrick Johnston Praveen Ramakrishnan Geethakumari Razan Mohty Samuel Yamshon Tsiporah Shore Urshila Durani Usama Gergis Yi Lin
Special Coverage
Voices
Sep 2, 2025, 22:37
Tyler Seibert: How Much Can A GG2 Prostate Cancer Grow in 2 Months?
Societies
Sep 2, 2025, 22:03
European Liver Screening Week - European Liver Patients'​ Association
Science
Sep 2, 2025, 21:19
Mohamed Emam Sobeih: The Efficacy of Benson’s Relaxation Technique on Anorexia and Sleep in Cancer Patients
Voices
Sep 2, 2025, 20:50
Anton Gokin: Latest Updates in Oncology Market and Science
Science
Sep 2, 2025, 20:26
Yinghui Li: Novel lncRNA PLUM Drives Chemoresistance in Multiple Myeloma Through PRC2 Pathway
Societies
Sep 2, 2025, 18:53
A Busy Month of Global Healthcare Innovation and Conferences - EHFF
Voices
Sep 2, 2025, 18:26
Tong Yin Shared Details of AstraZeneca’s ECP Symposium on Breast Cancer Diagnostics
Voices
Sep 2, 2025, 17:36
Tackling Hepatitis and Its Connection to Liver Cancer - European Cancer Organisation
Blog Posts
Sep 2, 2025, 17:24
Launching the 10th LuCE Report: Marking a Decade of Evidence from Lived Experience
Career Updates
Sep 2, 2025, 17:15
Joaquim Bosch-Barrera Begins New Role as Associate Adjunct Professor at ICO
Blog Posts
Sep 2, 2025, 17:08
Aria’s Story and the Fight for Better Treatments for Childhood Cancer - Children's Cancer Institute
Science
Sep 2, 2025, 16:54
Rishabh Jain: A-BRAVE Lesson - A "Negative" Trial Shifts the Conversation